Ruiz Hurtado, GemaRuilope Urioste, Luis Miguel2017-05-302017-05-302017Ruiz-Hurtado, G., & Ruilope, L. M. (2017). Sacubitril/valsartan in the treatment of arterial hypertension: An unaccomplished promise?. Hypertension Research, 40, 439-440. DOI: 10.1038/hr.2017.2709169636http://hdl.handle.net/11268/6447Arterial hypertension continues to be the leading cause of death worldwide and, unfortunately, remains uncontrolled in a significant percentage of hypertensive patients who do not attain the blood pressure (BP) goal that most guidelines recommend (<140/90 mm Hg). A lively debate began after the publication of the Systolic Blood Pressure Intervention Trial (SPRINT), in which a goal of 120 mm Hg was reported to be adequate in a portion of the hypertensive population.engSacubitril/valsartan in the treatment of arterial hypertension: An unaccomplished promise?journal article10.1038/hr.2017.27restricted accessHipertensiónEnfermedad cardiovascular